Amarin's (AMRN) Vascepa Tracking Well 3-Months In; Investors Eye Tier 2 Designation
Tweet Send to a Friend
Amarin (Nasdaq: AMRN) is trading strong amid positive comments from Leerink Swann today.
Analyst Joseph Schwartz said IMS Health's ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Analyst Joseph Schwartz said IMS Health's ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
